Protection of dogs against Canine Distemper (CDV) by vaccination with a canarypox virus recombinant expressing CDV F and HA glycoproteins:
M. Camila Pardo, John E. Bauman, and Marc Mackowiak. American Journal of Veterinary Research, Vol 58, No 8. 833-836. August 1997.

Efficacy of a New Canine origin, MLV vaccine against Canine Coronavirus: M. Camila Pardo, DVM, MS.  Marc Mackowiak, DVM, Canine Practice, Volume 24. No1, February 1999

Safety of a new modified live virus vaccine against canine coronavirus.M. Camila Pardo, DVM, MS.  Marc Mackowiak, DVM, Canine Practice 2000; 25(1): 16-19.

Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge: Fischer L, Tronel JP, Pardo-David C, Tanner P, Colombet G, Minke J, Audonnet JC,. VACCINE, Volume 4;20(29-30):3485-3497. October 2002 

Protection from challenge following a Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously. Grosenbaugh DA, Leard T, Pardo MC. Vet Ther. 2004;5(4):258-62.

Administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
Grosenbaugh DA, Leard T, Pardo MC. J Am Vet Med Assoc. 2006 Mar 1;228(5):726-7.

Immunization of Puppies in the presence of Maternally Derived Antibodies Against Canine Distemper Virus. MC Pardo, P Tanner, J Bauman, K Silver, L Fischer. Journal of Comparative Pathology. 2007 July. Volume 137 Supplement 1; S72-S75 

Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Minke JM, Toulemonde CE, Coupier H, Guigal PM, Dinic S, Sindle T, Jessett D, Bublot M, Pardo MC, Audonnet JC. Am. J. Vet. Res. 2007 Feb;68(2):213-9

Development and Registration of recombinant veterinary vaccines. The example of the Canarypox vector platform.  Poulet H, Minke JM, Pardo MC, Juillard V, Nordgren B, Audonnet JC. VACCINE 2007 Jul 26;25(30):5606-12 

Occurrence of canine parvovirus type 2c in the United States. Hong C, Decaro N, Desario C, Tanner P, Pardo MC, Sanchez S, Buonavoglia C, Saliki J. J Vet Diagn Invest 2007 Sep;19(5):535-539.

Fifteen-month duration of immunity for the serovar Grippotyphosa fraction of a tetravalent canine leptospirosis vaccine. Grosenbaugh DA, Pardo MC, Veterinary Record  2018 Feb 19